Fosinopril Sodium (fosinopril) NDC 69097-858

NDC codes

FDA NDC Directory

Product NDC (as listed)69097-858Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69097-0858Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69097-858-05	69097085805	90 TABLET in 1 BOTTLE (69097-858-05)Marketed from Jun 16, 2016
69097-858-15	69097085815	1000 TABLET in 1 BOTTLE (69097-858-15)Marketed from Jun 16, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fosinopril Sodium
Generic name (nonproprietary): fosinopril
Active ingredients: Fosinopril sodium — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cipla USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077222
Marketing start: Jun 16, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 69097-858_6d672087-9b6a-4afe-8c3e-0616943a82cfSPL ID 6d672087-9b6a-4afe-8c3e-0616943a82cfSPL set ID 736fe52f-69fb-48b2-b1c5-f06531878538RxCUI 857169, 857183, 857187UNII NW2RTH6T2NUPC 0369097857059, 0369097856052, 0369097858056
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469097085805 followed by a unit qualifier and the quantity

Package 69097-0858-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 20, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fosinopril sodium tablets are indicated for the treatment of hypertension. It may be used alone or in combination with thiazide diuretics. Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ). In using fosinopril sodium, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that fosinopril sodium does not have a similar …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)